At step 2 of the ich process, a consensus draft text or guideline, agreed by the appropriate ich expert working group, is transmitted by the ich assembly to the regulatory authorities of the ich regions for internal and external consultation, according to national or regional procedures. This guideline aims to optimize the use of pps using a globally harmonized framework. Harmonisation of regulatory “requirements” for patient preference studies (e22) key regulatory guidance:
Under this guideline, most covered federally regulated financial institutions (frfi) are subject to the mandatory exchange of variation margin (vm) and initial margin (im). The ich e22 guideline focuses on general considerations for patient preference studies (pps) to inform drug development and regulatory submissions for pharmaceutical products The revisions consist of two changes
Guideline implementation all guidelines quality guidelines safety guidelines multidisciplinary guidelines index of guidelines efficacy guidelines meddra ctd electronic standards (estri) reflection papers & discussion groups consideration documents cioms glossary of ich terms & definitions ich pqkm task force meetings ich calendar assembly.
